Home > Journals > La Rivista Italiana della Medicina di Laboratorio > Past Issues > La Rivista Italiana della Medicina di Laboratorio 2020 Dicembre;16(4) > La Rivista Italiana della Medicina di Laboratorio 2020 Dicembre;16(4):243-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ARTICOLO ORIGINALE   

La Rivista Italiana della Medicina di Laboratorio 2020 Dicembre;16(4):243-9

DOI: 10.23736/S1825-859X.20.00069-9

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Heart failure in frail elderly resident in a nurse house: prognostic significance of a multimarker approach

Sara VALVERDE 1, Roberto VALLE 2, Francesca GESSONI 1, Letizia VALLE 2, Massimo IACOVIELLO 3, Nadia ASPROMONTE 4, Gianluca GESSONI 5

1 Servizio di Medicina di Laboratorio, Ospedale Madonna della Navicella, Chioggia, Venice, Italy; 2 Cardiologia e Unità Coronarica, Ospedale Madonna della Navicella, Chioggia, Venice, Italy; 3 UOC Cardiologia Universitaria, AOU Policlinico Consorziale di Bari, Bari, Italy; 4 Dipartimento di Scienze Cardiologiche e Toraciche, Policlinico Universitario A. Gemelli, Rome, Italy; 5 Servizio di Medicina Trasfusionale, Ospedale Dell’Angelo, Mestre, Venice, Italy



BACKGROUND: Heart failure (HF) has been defined a modern pandemic. The complex array of physiologic, psychological, social and health care delivery issues makes it a challenging chronic disease to manage. Our study thus aimed to evaluate a multi-marker approach to assess prognosis of HF.
METHODS: We considered 202 elderly in the nursing home in Chioggia (Venice, Italy). Each subject underwent clinical evaluation, echocardiography, determination of high sensitivity troponin I (hs-TnI), galectin-3 (GAL), cystatin C (CYS) and brain natriuretic peptides (BNP) by routine methods. These subjects were followed for 24 months after their inclusion in the study and during this period overall mortality was recorded.
RESULTS: After a 24-month follow-up (FU) the overall mortality was 41.6%. In these patients’ series raised biomarkers serum concentration constituted a significant hazard ratio: 3.83 for BNP, 3.24 for CYS, 5.65 for GAL and 5,76 for hs-TnI. A poorest prognosis was observed in subjects with raised concentration for multiple biomarkers.
CONCLUSIONS: In the considered population, BNP, CYS, GAL and hs-TnI were independently associated with higher risk of negative outcome. In addition, according to our experience, the simultaneous dosage of the four considered biomarkers improves the correlation with the prognosis. Further studies in similar populations are needed to confirm our results.


KEY WORDS: Biomarkers; Aged; Heart failure; Prognosis

top of page